Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets – Data Report by DeciBio Consulting LLC

LOS ANGELES–(BUSINESS WIRE)–#MRD–A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe’s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a … [Read more…]

Syngenta Unlocks Wheat’s Potential and Prepares to Launch X-Terra® Hybrid Wheat Across Europe

Genetic complexity of wheat has long thwarted efforts to hybridize wheat, to realize the benefits of improved yield and the combination of beneficial traits X-Terra® is Europe’s first commercially scalable hybrid wheat BASEL, Switzerland–(BUSINESS WIRE)–Wheat is the world’s most genetically complex staple crop, with the wheat genome nearly six times the size of the human … [Read more…]

Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease

– MAJESTY, the first global Phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years – – Up to 30% of people with membranous nephropathy progress to kidney failure over 10 years despite current treatment approaches; achieving complete remission can help delay or prevent this – – Gazyva … [Read more…]

CWCI: COVID-19 Drove Recent Volatility in California Work Injury & Illness Trends

OAKLAND, Calif.–(BUSINESS WIRE)–#COVID19–After surging during the height of the COVID-19 pandemic, the number of nonfatal work injuries and illnesses in California returned to pre-pandemic levels in 2024 according to a California Workers’ Compensation Institute (CWCI) review of data from the California Department of Industrial Relations (DIR) Director’s Office of Research. Recent results from California’s Survey … [Read more…]

LifeLink Foundation Appoints Kelly Cullen, RN, MBA, as Chief Operating Officer

Veteran nurse and healthcare executive brings heart-centered leadership, and operational excellence to advance the lifesaving work of LifeLink ATLANTA–(BUSINESS WIRE)–#donor—LifeLink Foundation today announced that Kelly Cullen, RN, MBA, has joined the organization as Chief Operating Officer (COO) to support the mission and continued growth of LifeLink. Cullen will provide strategic and operational leadership to advance … [Read more…]

Ottawa projected to lose funding for 725 frontline health care staff and nearly 200 hospital beds by 2027-28: new report

Planned funding cuts by the provincial government will lengthen wait-times and worsen patient care in hospitals, warns CUPE OTTAWA–(BUSINESS WIRE)–As hospitals cut hundreds of jobs and eliminate vacant positions amidst budgetary constraints imposed by the Conservative government, the largest health care union in Ontario is warning about longer wait-times, rushed care, preventable mistakes, and overcrowded … [Read more…]

Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory Medicine

WILMINGTON, Del.–(BUSINESS WIRE)–Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) demonstrated statistically significant and clinically meaningful improvements in patients with uncontrolled asthma compared with dual-combination inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) medicines: Symbicort (budesonide/formoterol fumarate or BFF, a standard … [Read more…]

Paradigm Signs Definitive Agreement to Be Acquired by Patient Square Capital

WALNUT CREEK, Calif.–(BUSINESS WIRE)–Paradigm (“Paradigm” or the “Company”), a specialty care management organization focused on delivering solutions that improve outcomes for individuals with complex injuries and diagnoses, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (“Patient Square”), a leading health care investment firm. This planned investment … [Read more…]

Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results

FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / … [Read more…]